학술논문

BET bromodomain inhibition suppresses graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Document Type
Article
Source
Blood. 4/23/2015, Vol. 125 Issue 17, p2724-2728. 5p.
Subject
*GRAFT versus host disease
*BONE marrow transplantation
*BROMODOMAIN-containing proteins
*HISTONE acetylation
*LABORATORY mice
Language
ISSN
0006-4971
Abstract
Acute g raft-versus-host d isease (GVHD) is the m ajor obstacle of allogeneic bone marrow transplantation (BMT). Bromodomain and extra-terminal (BET) protein inhibitors selectively block acetyl-binding pockets of the bromodomains and modulate histone acetylation, Here, we report that inhibition of BET b romodomain (BRD) proteins with I-BET151 alters cytokine expression in dendritic cells (DCs) and T cells, including surface costimulatory molecules, in vitro and in vivo cytokine secretion, and expansion. Mechanistic studies with I-BET151 and JQ1, another inhibitor, d emonstrate that these effects could be from disruption of association between BRD4 and acetyl-310 RelA of nuclear factor kappa B. Short-term administration early during BMT reduced GVHD severity and improved mortality in two different allogeneic BMT models but retained sufficient graft-versustumor effect. Thus inhibiting BRD proteins may serve as a novel approach for preventing GVHD. [ABSTRACT FROM AUTHOR]